![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Dr. Reddy’s Laboratories enters into a Voluntary Licensing Agreement with Lilly to Expand Access...
Dr. Reddy's Laboratories Ltd. announced that it has entered into a royalty-free, non-exclusive voluntary licensing...
Novavax Covid-19 vaccine provides cross-protection against B.1.351 variant
The protein-based vaccine candidate NVX-CoV2373 is made from the genetic sequence of the first SARS-CoV-2...
3P Biopharmaceuticals and Buzzard Pharmaceuticals start a collaboration to develop a new treatment to...
3P Biopharmaceuticals, a leading Contract Development and Manufacturing Organisation CDMO specialized in the process development...
Vectura and Inspira Pharmaceuticals Sign Agreement to Develop Potential Inhaled Treatment for COVID-19
Vectura Group plc, an industry leading inhalation CDMO, and Inspira Pharmaceuticals Limited, a new UK-based...
Sanofi establishes three-year collaboration with Stanford Medicine to accelerate immunology research
Sanofi has entered into a three-year research collaboration with Stanford University School of Medicine. Together,...
Moderna Announces Additional Investments to Increase Global Supply for COVID-19 Vaccine to up to...
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced it is...
CENTOGENE Extends Partnership With Takeda
Centogene N.V., a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic...
Sanofi to invest in a leading-edge production site in Singapore; continues to strengthen its...
Sanofi announced a €400 million investment over five years to create a unique vaccine production...
Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations
Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, announced its participation...
Sanofi to invest in a leading-edge production site in Singapore; continues to strengthen its...
Sanofi announced a €400 million investment over five years to create a unique vaccine production...